Novo Nordisk Company Information

Novo Nordisk A/S's employee growth, exchange listings and data sources


Key Information

  • Name: Novo Nordisk A/S
  • Ticker: NOVO B
  • Exchange: CPSE
  • Founded: 1923
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: kr.2.125t
  • Shares outstanding: 2.26b
  • Website: https://www.novonordisk.com

Number of Employees


Location

  • Novo Nordisk A/S
  • Novo AllE 1
  • Bagsvaerd
  • Capital Region of Denmark
  • 2880
  • Denmark


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NVONYSE (New York Stock Exchange)ADRUSUSDApr 1981
NOVADB (Deutsche Boerse AG)ADRDEEURApr 1981
NOVAXTRA (XETRA Trading Platform)ADRDEEURApr 1981
NVO NBMV (Bolsa Mexicana de Valores)ADRMXMXNApr 1981
0TDDLSE (London Stock Exchange)ADRGBUSDApr 1981
NONO.FOTCPK (Pink Sheets LLC)YesClass B Common SharesUSUSDJan 1992
23159222BRSE (Berne Stock Exchange)YesClass B Common SharesCHCHFJan 1992
0QIULSE (London Stock Exchange)YesClass B Common SharesGBDKKJan 1992
NOVCDB (Deutsche Boerse AG)YesClass B Common SharesDEEURJan 1992
NOVO BCPSE (OMX Nordic Exchange Copenhagen)YesClass B Common SharesDKDKKJan 1992
NOVXTRA (XETRA Trading Platform)YesClass B Common SharesDEEURJan 1992
NOVOBCBATS-CHIXE (BATS 'Chi-X Europe')YesClass B Common SharesGBDKKJan 1992
NNORWBAG (Wiener Boerse AG)YesClass B Common SharesATEURJan 1992
NOVOB NBMV (Bolsa Mexicana de Valores)YesClass B Common SharesMXMXNJan 1992
NOVCBUL (Bulgaria Stock Exchange)YesClass B Common SharesBGEURJan 1992
N1VO34BOVESPA (Bolsa de Valores de Sao Paulo)BDR EACH 8 REPR 1 ADRBRBRLSep 2022

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/02/04 00:00
End of Day Share Price2023/02/03 00:00
Earnings2022/12/31
Annual Earnings2022/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.